2010 Canadian Hypertension Education Program (CHEP) recommendations: The scientific summary - An update of the 2010 theme and the science behind new CHEP recommendations

Canadian Journal of Cardiology

Volumn 26, Issue 5, 2010, Pages 236-240

  Campbell, Norman R C ^a   Kaczorowski, Janusz ^b   Lewanczuk, Richard Z ^c   Feldman, Ross ^d   Poirier, Luc ^e   Kwong, Margaret Moy Lum ^f   Lebel, Marcel ^e   McAlister, Finlay A ^c   Tobe, Sheldon W ^g  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clinical practice guidelines; High blood pressure; Hypertension; Knowledge translation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RAMIPRIL; TELMISARTAN;

BLOOD PRESSURE MONITORING; EDUCATION PROGRAM; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERNET; ISCHEMIC HEART DISEASE; SHORT SURVEY; SODIUM INTAKE;

EID: 77952296364     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70377-9     Document Type: Short Survey

References (27)

1. Petrella RJ, Campbell NRC. Awareness and misconception of hypertension in Canada: Results of a national survey. Can J Cardiol 2005;21:589-593
2. Campbell NRC, Conradson HE, Kang J, Brant R, Anderson T. Automated assessment of blood pressure using BpTRU compared to assessments by a trained technician and a clinic nurse. Blood Press Monit 2005;10:257-262 (Pubitemid 41502883)
3. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens 2008;21:280-283 (Pubitemid 351323269)
4. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Press Monit 2006;11:59-62. (Pubitemid 44090017)
5. Myers MG, Godwin M. Automated measurement of blood pressure in routine clinical practice. J Clin Hypertens 2007;9:267-270
6. Campbell NRC, McKay DW, Conrdason H, Lonn E, Title LM, Anderson T. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid-intima medial thickness in male firefighters. J Hum Hypertens 2007;21:588-590 (Pubitemid 47018634)
7. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord 2005;5:18-23. (Pubitemid 41460660)
8. Panel on Dietary Reference Intakes for Electrolytes and Water and Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride and Sulfate. 1-640. Washington: National Academies Press, 2004.
9. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-1559 (Pubitemid 351522739)
10. Yusuf S, Teo K, Anderson C, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet 2008;372:1174-1183
11. Yusuf S, Diener HC, Sacco RL, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008;359:1225-1237
12. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428
13. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009;6:e1000058.
14. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: Health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370:2044-2053 (Pubitemid 50007973)
15. Appel LJ. Another major role for dietary sodium reduction: Improving blood pressure control in patients with resistant hypertension. Hypertension 2009;54:444-446
16. Lachaine J, Petrella RJ, Merikle E, Ali F. Choices, persistence and adherence to antihypertensive agents: Evidence from RAMQ data. Can J Cardiol 2008;24:269-273 (Pubitemid 351771460)
17. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999;160:31-37 (Pubitemid 29054224)
18. Bourgault C, Senecal M, Brisson M, Marentette MA, Gregoire J-P. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: A population-based study. J Hum Hypertens 2005;19:607-613 (Pubitemid 41131661)
19. Costanzo P, Perrone-Filardi P, Petretta M, et al. Calcium channel blockers and cardiovascular outcomes: A meta-analysis of 175,634 patients. J Hypertens 2009;27:1136-1151
20. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents. A meta-analysis. Hypertension 2010;55:399-407.
21. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2009;25:287-298
22. Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial. Lancet 2008;372:547-553
23. Godwin M, Pike A, Kirby A, Jewer C, Murphy L. Prehypertension and hypertension in a primary care practice. Can Fam Physician 2008;54:1418-1423
24. Leenen FH, Dumais J, McInnis NH, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008;178:1441-1449 (Pubitemid 351775721)
25. Campbell NR, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009;53:128-134
26. Hemmelgarn BR, Chen G, Walker R, et al. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008;24:507-512
27. Onysko J, Maxwell C, Eliasziw M, Zhang J, Johansen H, Campbell N. Large increases in hypertension diagnosis and treatment in Canada following a health care professional education program. Hypertension 2006;48:853-860 (Pubitemid 44610997)